iBio, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $100 | $200 |
Gross Profit | -250 | -241 | -189 | 200 |
EBITDA | -7,458 | -8,711 | -5,395 | -4,834 |
EBIT | -7,708 | -8,952 | -5,684 | -5,119 |
Net Income | -7,730 | -8,993 | -5,720 | -5,163 |
Net Change In Cash | 0 | 0 | 100 | 200 |
Free Cash Flow | -6,095 | -5,757 | -5,697 | -4,616 |
Cash | 47,631 | 28,672 | 28,111 | 8,582 |
Basic Shares | 119,600 | 99,133 | 52,981 | 16,423 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $400 | $225 | $50 | $1,884 |
Gross Profit | 400 | 225 | 50 | -1,907 |
EBITDA | -17,039 | -14,021 | -28,107 | -25,722 |
EBIT | -18,165 | -15,271 | -29,311 | -29,513 |
Net Income | -18,377 | -24,907 | -29,311 | -50,391 |
Net Change In Cash | 400 | 225 | 50 | 1,884 |
Free Cash Flow | -15,320 | -18,764 | -36,174 | -45,132 |
Cash | 8,582 | 14,210 | 7,326 | 22,676 |
Basic Shares | 10,499 | 3,831 | 612 | 17 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.06 |
2025-12-31 | -$0.09 |
2025-09-30 | -$0.29 |
2025-06-30 | -$0.32 |